Patent AnalyticsExaminers
Rankings

Company or institution

ASTELLAS PHARMA INC.

434 applicationsfiled 2006 to 2026

Allowance rate
54%
−21 pts vs the USPTO range 49% to 59%
Rejections before allowance
1.4
−0.2 vs the USPTO
Months to first action
19.6 mo
+1.0 vs the USPTO
Needed an RCE
15%
−12 pts vs the USPTO

Timeline

Applications by filing year: drag across the years to study a period

Allowed in green, abandoned in red, pending in grey. The figures above and the charts that can be recomputed by filing year follow the span you pick.

Compared with the office

Against every applicant before the USPTO

Unlock the comparison with the officeFree with an account. No card needed.

Create a free account

Trend

Allowance by filing year

Unlock the trendIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Domains

Where the applications fall

CPC subclasses

A61K Medical preparations175 apps
C07D Heterocyclic compounds132 apps
C07K Peptides52 apps
A61P Therapeutic activity of compounds17 apps
C07C 15 apps
G01N Investigating or analysing materials10 apps

Art units

162450 apps
162639 apps
162538 apps
162833 apps
162724 apps
162920 apps

Who represents them

Law firms and agents on their applications

Bars show the share of decided applications that were allowed.

Unlock the firms on their applicationsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Rejection fingerprint

What gets rejected, by statute

Share of parsed office actions raising each ground; blue is the USPTO.

Unlock the rejection fingerprintIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

What works

Allowance by strategy used

Unlock what works for this filerIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Interviews

Does an interview help?

Unlock the interview figuresFree with an account. No card needed.

Create a free account

Applications

Every application in the record

ApplicationTitleFiledStatusRejectionsRCEsTo 1st action
19612059ANTIBODY-DRUG CONJUGATE CONTAINING HETEROCYCLIC COMPOUND HAVING MUTANT KRAS PROTEIN…2026-08-04Pending00n/a
19687560HETEROCYCLIC COMPOUND ACTING ON G12D MUTANT KRAS PROTEIN2026-05-26Pending00n/a
19589393CARBAMOYL LIPID HAVING CYCLIC GROUP IN SIDE CHAIN, LIPID NANOPARTICLES THEREOF, AND…2026-05-21Pending00n/a
15376271Method and apparatus for adaptive signal processing2012-01-10Allowed1012.0 mo
15383090Composition and method for controlled release2015-02-11Abandoned4123.0 mo
15215727Distributed ledger transaction verification2018-03-12Allowed3020.0 mo
15741236Thermal management of battery assemblies2021-04-13Pending2117.0 mo
15385708Machine learning model for anomaly detection2012-05-14Allowed1014.0 mo
15293837Wireless power transfer coil arrangement2015-06-15Abandoned4125.0 mo
15835811Catalyst for selective hydrogenation2018-07-16Allowed3022.0 mo
Unlock all 434 applications, each with its full timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in